Christoph Sven Hoffmann

Sallfort Privatbank AG provides commercial banking, investment advisory, and asset management services. It also specializes in private equity, corporate finance, e-banking, and art consulting. The company was founded in 1981 and is headquartered in Zurich, Switzerland.

Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier.

Sallfort Privatbank AG provides commercial banking, investment advisory, and asset management services. It also specializes in private equity, corporate finance, e-banking, and art consulting. The company was founded in 1981 and is headquartered in Zurich, Switzerland.

Sallfort Privatbank AG provides commercial banking, investment advisory, and asset management services. It also specializes in private equity, corporate finance, e-banking, and art consulting. The company was founded in 1981 and is headquartered in Zurich, Switzerland.

Sallfort Privatbank AG provides commercial banking, investment advisory, and asset management services. It also specializes in private equity, corporate finance, e-banking, and art consulting. The company was founded in 1981 and is headquartered in Zurich, Switzerland.

Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier.

Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier.

Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier.